From the genetics of ankylosing spondylitis to new biology and drug target discovery
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatme...
Prif Awduron: | Zaarour, N, Li, Y, Shi, H, Bowness, P, Chen, L |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Frontiers Media
2021
|
Eitemau Tebyg
-
OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
gan: Bowness, P
Cyhoeddwyd: (2012) -
GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
gan: Shi, H, et al.
Cyhoeddwyd: (2020) -
The immunology of Ankylosing Spondylitis
gan: Bowness, P
Cyhoeddwyd: (2011) -
New developments in our understanding of Ankylosing Spondylitis pathogenesis
gan: Voruganti, A, et al.
Cyhoeddwyd: (2020) -
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
gan: Fischer, R, et al.
Cyhoeddwyd: (2012)